What is the current Price Target for the Candel Therapeutics Inc stock?

The average Candel Therapeutics Inc target price is $24.48. This is 355.02% higher than the current stock price. The highest price target is 387.92%, the lowest is 31.41%. 8 Analysts have issued a price target Candel Therapeutics Inc 2026 .

How high will the Candel Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Candel Therapeutics Inc stock will rise. The performance of stocks, including the Candel Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Candel Therapeutics Inc stock today?

The performance of Candel Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Candel Therapeutics Inc stock fall?

The decline in Candel Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Candel Therapeutics Inc Forecast, price target & analysts

$5.23

2.79% today

Nasdaq, Nov 03, 04:51 pm CET

ISIN

US1374041093

Symbol

CADL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Candel Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Candel Therapeutics Inc Classifications & Recommendation:

Buy

83%

Hold

17%

Candel Therapeutics Inc Price Target

Target Price	$24.48
Price	$5.38
Potential	355.02% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Candel Therapeutics Inc 2026 . The average Candel Therapeutics Inc target price is $24.48. This is 355.02% register free of charge higher than the current stock price. The highest price target is $26.25 387.92% register free of charge , the lowest is $7.07 31.41% register free of charge .
	A rating was issued by 12 analysts: 10 Analysts recommend Candel Therapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Candel Therapeutics Inc stock has an average upside potential 2026 of 355.02% register free of charge . Most analysts recommend the Candel Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.74	-0.36
	32.82%	79.31%
P/E		negative

8 Analysts have issued a Candel Therapeutics Inc forecast for earnings per share. The average Candel Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.74	32.82%
2025	$-0.36 79.31% Unlock
2026	$-0.91 152.78% Unlock
2027	$-0.25 72.53% Unlock

Current	-12.81	272.85%
2025	-15.02 17.26% Unlock
2026	-5.88 60.85% Unlock
2027	-21.82 271.09% Unlock

Candel Therapeutics Inc...

Current Candel Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Stephens & Co.	Locked ➜ Locked	Locked	Oct 28 2025
LifeSci Capital	Locked ➜ Locked	Locked	Oct 21 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 29 2025
B of A Securities	Locked ➜ Locked	Locked	Sep 03 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 11 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 14 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Feb 26 2025

Analyst Rating	Date
Locked Stephens & Co.: Locked ➜ Locked	Oct 28 2025
Locked LifeSci Capital: Locked ➜ Locked	Oct 21 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 29 2025
Locked B of A Securities: Locked ➜ Locked	Sep 03 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 11 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 14 2025
Locked Canaccord Genuity: Locked ➜ Locked	Feb 26 2025

Discover more stocks with a high price target

TUI 51.99%

Adidas 48.21%

Deutsche Telekom 44.14%

Novo Nordisk 42.05%

BYD 37.26%

Meta Platforms (Facebook) 36.95%

BioNTech SE - ADR 34.48%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now